Abstract
CYP3A44 and CYP3A41 are female-specific CYP3A in the mouse liver. In primary cultured mouse hepatocytes, dexamethasone concentration-dependently induced CYP3A44 mRNA, and the highest response was seen at 10-5 M. In contrast, CYP3A41 mRNA expression was highest at lower concentrations (10-7 or 10-6 M). At submicromolar concentration (10-7 M), the induction of CYP3A44 mRNA was very slight, but strongly enhanced induction was observed by the simultaneous addition of growth hormone (GH). Similar enhancement was also observed in CYP3A41 mRNA expression. Continuous exposure to GH, which mimics female-type secretion from the pituitary gland, was effective to enhance the expression of both mRNAs, but discontinuous exposure (male-type) was not. This synergistic induction of CYP3A44 mRNA was further enhanced by the transfection of glucocorticoid receptor (GR) expression plasmid or by the cotransfection of pregnane X receptor (PXR) and retinoid X receptor (RXR) α expression plasmids. Similar synergistic induction was seen in CYP3A41 mRNA by the transfection of GR expression plasmid but was not enhanced by cotransfection of PXR and RXR expression plasmids. These observations suggest that functional cross-talk between signaling pathways of female-type GH secretion and glucocorticoid hormone might be involved in the female-predominant expression of both genes. Additionally, one or more nuclear receptors mediating induction by glucocorticoid hormone are employed for collaboration with GH.
Footnotes
-
This study was partly supported by Grants-in-Aid from the Japanese Ministry of Education, Culture, Sports, Science and Technology and from the Smoking Research Foundation.
-
Article, publication date, and citation information can be found at http://dmd.aspetjournals.org.
-
doi:10.1124/dmd.107.019935.
-
ABBREVIATIONS: GH, growth hormone; PXR, pregnane X receptor; GR, glucocorticoid receptor; PCR, polymerase chain reaction; rh, recombinant human; MSG, monosodium l-glutamate; DEX, dexamethasone; RU486, 11β-[4-dimethylamino]phenyl-17β-hydroxy-17-[1-propynyl]estra-4,9-dien-3-one; RXR, retinoid X receptor; RT, reverse transcription; GAPDH, glyceraldehyde 3-phosphate dehydrogenase; m, mouse; STAT, signal transducer and activator of transcription; ANOVA, analysis of variance.
- Received November 29, 2007.
- Accepted January 31, 2008.
- The American Society for Pharmacology and Experimental Therapeutics
DMD articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|